Wildcat Capital Management, LLC Quant / Systematic

Location: New York, NY

CIK: 0001582384 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Jul 18, 2025

Total Value: $168M (100.0% shares, 0.0% debt)

Holdings (6)

ULCC FRONTIER GROUP HLDGS INC 60.5%

Value $102M Shares 28,061,351 Est. Cost $5.99 Unrealized -38.9%

RLX RLX TECHNOLOGY INC 23.7%

Value $39.88M Shares 18,046,195 Est. Cost $4.05 Unrealized —

TIC ACUREN CORP 9.8%

Value $16.56M Shares 1,500,000 Est. Cost $12.06 Unrealized -14.6%

URGN UROGEN PHARMA LTD 4.0%

Value $6.79M Shares 495,606 Est. Cost $34.01 Unrealized -71.8%

ALLO ALLOGENE THERAPEUTICS INC 1.9%

Value $3.121M Shares 2,920,787 Est. Cost $17.44 Unrealized -92.4%

— SILEXION THERAPEUTICS CORP 0.1%

Value $91,877 Shares 113,428 Est. Cost $2.01 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ULCC	FRONTIER GROUP HLDGS INC	28,061,351	$102M	60.5%	$5.99	-38.9%	COM	35909R108
RLX	RLX TECHNOLOGY INC	18,046,195	$39.88M	23.7%	$4.05	—	SPONSORED ADS	74969N103
TIC	ACUREN CORP	1,500,000	$16.56M	9.8%	$12.06	-14.6%	COM	00510N102
URGN	UROGEN PHARMA LTD	495,606	$6.79M	4.0%	$34.01	-71.8%	COM	M96088105
ALLO	ALLOGENE THERAPEUTICS INC	2,920,787	$3.121M	1.9%	$17.44	-92.4%	COM	019770106
—	SILEXION THERAPEUTICS CORP	113,428	$91,877	0.1%	$2.01	—	SHS NEW	G1281K122